Pharmacokinetic and Pharmacodynamic Comparison of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant Patients, American Journal of Transplantation, vol.44, issue.4, pp.888-898, 2007. ,
DOI : 10.1097/00007890-199609150-00022
Recombinant human inosine monophosphate dehydrogenase type I and type II proteins, Biochemical Pharmacology, vol.49, issue.9, pp.1323-1329, 1995. ,
DOI : 10.1016/0006-2952(95)00026-V
IDENTIFICATION OF THE UDP-GLUCURONOSYLTRANSFERASE ISOFORMS INVOLVED IN MYCOPHENOLIC ACID PHASE II METABOLISM, Drug Metabolism and Disposition, vol.33, issue.1, pp.139-146, 2005. ,
DOI : 10.1124/dmd.104.001651
THE MAIN ROLE OF UGT1A9 IN THE HEPATIC METABOLISM OF MYCOPHENOLIC ACID AND THE EFFECTS OF NATURALLY OCCURRING VARIANTS, Drug Metabolism and Disposition, vol.32, issue.8, pp.775-778, 2004. ,
DOI : 10.1124/dmd.32.8.775
Influence of Nonsynonymous Polymorphisms of UGT1A8 and UGT2B7 Metabolizing Enzymes on the Formation of Phenolic and Acyl Glucuronides of Mycophenolic Acid, Drug Metabolism and Disposition, vol.34, issue.9, pp.1539-1545, 2006. ,
DOI : 10.1124/dmd.106.010553
Effect of Mycophenolate Acyl-Glucuronide on Human Recombinant Type 2 Inosine Monophosphate Dehydrogenase, Clinical Chemistry, vol.55, issue.5, pp.986-993, 2009. ,
DOI : 10.1373/clinchem.2008.113936
Clinical Pharmacokinetics of Mycophenolate Mofetil, Clinical Pharmacokinetics, vol.34, issue.6, pp.429-455, 1998. ,
DOI : 10.2165/00003088-199834060-00002
Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus, Xenobiotica, vol.26, issue.3, pp.229-235, 2013. ,
DOI : 10.1124/dmd.105.006122
ROLE OF MRP2 IN THE HEPATIC DISPOSITION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITES: EFFECT OF CYCLOSPORINE, Drug Metabolism and Disposition, vol.34, issue.2, pp.261-266, 2006. ,
DOI : 10.1124/dmd.105.006122
The Role of Organic Anion???Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics, Clinical Pharmacology & Therapeutics, vol.87, issue.1, pp.100-108, 2010. ,
DOI : 10.1086/379378
URL : https://hal.archives-ouvertes.fr/inserm-00415314
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation, Expert Opinion on Drug Metabolism & Toxicology, vol.35, issue.3, pp.731-743, 2011. ,
DOI : 10.1073/pnas.0506483102
URL : https://hal.archives-ouvertes.fr/inserm-00577136
Pharmacogenetic influences on mycophenolate therapy, Pharmacogenomics, vol.11, issue.3, pp.369-390, 2010. ,
DOI : 10.2217/pgs.10.9
Multidrug Resistance Protein 2 Genetic Polymorphisms Influence Mycophenolic Acid Exposure in Renal Allograft Recipients, Transplantation, vol.82, issue.8, pp.1074-1084, 2006. ,
DOI : 10.1097/01.tp.0000235533.29300.e7
Genetic Determinants of Mycophenolate-Related Anemia and Leukopenia After Transplantation, Transplantation, vol.91, issue.3, pp.309-316, 2011. ,
DOI : 10.1097/TP.0b013e318200e971
Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients, Nephrology Dialysis Transplantation, vol.27, issue.9, pp.3651-3659, 2012. ,
DOI : 10.1093/ndt/gfs146
The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review, Transplantation, vol.83, issue.12, pp.1525-1535, 2007. ,
DOI : 10.1097/01.tp.0000268306.41196.2c
Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats, Drug Metabolism and Disposition, vol.35, issue.3, pp.449-454, 2007. ,
DOI : 10.1124/dmd.106.012013
Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/Thymoglobulin: One Year Follow-Up, Transplantation, vol.86, issue.1, pp.67-74, 2008. ,
DOI : 10.1097/TP.0b013e3181734b4a
Characterization of a Phase 1 Metabolite of Mycophenolic Acid Produced by CYP3A4/5, Therapeutic Drug Monitoring, vol.26, issue.6, pp.600-608, 2004. ,
DOI : 10.1097/00007691-200412000-00004